Literature DB >> 26224629

CYLD and the NEMO Zinc Finger Regulate Tumor Necrosis Factor Signaling and Early Embryogenesis.

Yongge Zhao1, Chi A Ma2, Liming Wu2, Kazuhiro Iwai3, Jonathan D Ashwell4, Eugene M Oltz5, Dean W Ballard6, Ashish Jain7.   

Abstract

NF-κB essential modulator (NEMO) and cylindromatosis protein (CYLD) are intracellular proteins that regulate the NF-κB signaling pathway. Although mice with either CYLD deficiency or an alteration in the zinc finger domain of NEMO (K392R) are born healthy, we found that the combination of these two gene defects in double mutant (DM) mice is early embryonic lethal but can be rescued by the absence of TNF receptor 1 (TNFR1). Notably, NEMO was not recruited into the TNFR1 complex of DM cells, and consequently NF-κB induction by TNF was severely impaired and DM cells were sensitized to TNF-induced cell death. Interestingly, the TNF signaling defects can be fully rescued by reconstitution of DM cells with CYLD lacking ubiquitin hydrolase activity but not with CYLD mutated in TNF receptor-associated factor 2 (TRAF2) or NEMO binding sites. Therefore, our data demonstrate an unexpected non-catalytic function for CYLD as an adapter protein between TRAF2 and the NEMO zinc finger that is important for TNF-induced NF-κB signaling during embryogenesis.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CYLD; NEMO; NF-κB (NF-KB); cell signaling; immunodeficiency; protein complex; tumor necrosis factor (TNF)

Mesh:

Substances:

Year:  2015        PMID: 26224629      PMCID: PMC4571959          DOI: 10.1074/jbc.M115.658096

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  NF-kappa B activation by tumor necrosis factor and interleukin-1.

Authors:  Z Cao; M Tanaka; C Regnier; M Rothe; A Yamit-hezi; J D Woronicz; M E Fuentes; M H Durnin; S A Dalrymple; D V Goeddel
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1999

2.  Identification of the familial cylindromatosis tumour-suppressor gene.

Authors:  G R Bignell; W Warren; S Seal; M Takahashi; E Rapley; R Barfoot; H Green; C Brown; P J Biggs; S R Lakhani; C Jones; J Hansen; E Blair; B Hofmann; R Siebert; G Turner; D G Evans; C Schrander-Stumpel; F A Beemer; A van Den Ouweland; D Halley; B Delpech; M G Cleveland; I Leigh; J Leisti; S Rasmussen
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

Review 3.  The TNF superfamily.

Authors:  Carl F Ware
Journal:  Cytokine Growth Factor Rev       Date:  2003 Jun-Aug       Impact factor: 7.638

4.  Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

Authors:  Olivier Micheau; Jürg Tschopp
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

Review 5.  Regulation of death receptor signaling by the ubiquitin system.

Authors:  I E Wertz; V M Dixit
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

6.  Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.

Authors:  A Jain; C A Ma; S Liu; M Brown; J Cohen; W Strober
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

7.  Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency.

Authors:  Stephane T Temmerman; Chi A Ma; Yongge Zhao; Jeffrey Keenan; Ivona Aksentijevich; Margaret Fessler; Margaret R Brown; Alan Knutsen; Ralph Shapiro; Ashish Jain
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

8.  Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality.

Authors:  T S Doi; M W Marino; T Takahashi; T Yoshida; T Sakakura; L J Old; Y Obata
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

9.  CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.

Authors:  Eirini Trompouki; Eudoxia Hatzivassiliou; Theodore Tsichritzis; Hannah Farmer; Alan Ashworth; George Mosialos
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

10.  The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma.

Authors:  Kohei Saito; Takanori Kigawa; Seizo Koshiba; Kazuo Sato; Yo Matsuo; Ayako Sakamoto; Tetsuo Takagi; Mikako Shirouzu; Takashi Yabuki; Emi Nunokawa; Eiko Seki; Takayoshi Matsuda; Masaaki Aoki; Yukako Miyata; Noriko Hirakawa; Makoto Inoue; Takaho Terada; Takahiro Nagase; Reiko Kikuno; Manabu Nakayama; Osamu Ohara; Akiko Tanaka; Shigeyuki Yokoyama
Journal:  Structure       Date:  2004-09       Impact factor: 5.006

View more
  5 in total

1.  The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.

Authors:  Yan-Xiao Ji; Zan Huang; Xia Yang; Xiaozhan Wang; Ling-Ping Zhao; Pi-Xiao Wang; Xiao-Jing Zhang; Michele Alves-Bezerra; Lin Cai; Peng Zhang; Yue-Xin Lu; Lan Bai; Mao-Mao Gao; Huan Zhao; Song Tian; Yong Wang; Zhi-Xiang Huang; Xue-Yong Zhu; Yan Zhang; Jun Gong; Zhi-Gang She; Feng Li; David E Cohen; Hongliang Li
Journal:  Nat Med       Date:  2018-01-01       Impact factor: 53.440

2.  All-atom molecular dynamics comparison of disease-associated zinc fingers.

Authors:  Ryan C Godwin; William H Gmeiner; Freddie R Salsbury
Journal:  J Biomol Struct Dyn       Date:  2017-10-03

3.  Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.

Authors:  Adnan Erol
Journal:  Cancer Manag Res       Date:  2022-08-05       Impact factor: 3.602

4.  Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production.

Authors:  Gui-Ru Wu; Tian-Chen Mu; Zhen-Xing Gao; Jun Wang; Man-Sun Sy; Chao-Yang Li
Journal:  J Biol Chem       Date:  2017-09-12       Impact factor: 5.157

Review 5.  The role of K63-linked polyubiquitination in cardiac hypertrophy.

Authors:  Kaowen Yan; Murugavel Ponnusamy; Ying Xin; Qi Wang; Peifeng Li; Kun Wang
Journal:  J Cell Mol Med       Date:  2018-08-13       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.